choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Pacira Pharmaceuticals IPO

Pacira Pharmaceuticals IPO Newsletter
  • IPO Update: PainReform Readies U.S. IPO Plan 06 Aug 2020 18:59 GMT

    … are developing treatments include: Pacira Pharmaceuticals (PCRX) Fresenius Kabi USA … Source: Company registration statement IPO Details PRFX intends to … S. IPOs with IPO Edge research. Members of IPO Edge get … in my personal IPO portfolio, upon IPO. Editor…

  • PainReform Seeks U.S. IPO For Phase 3 Trials 15 Jul 2020 22:36 GMT

    … learn more about the IPO from management. Company … are developing treatments include: Pacira Pharmaceuticals (PCRX) Fresenius Kabi USA … liabilities. (Unaudited, interim) IPO Details PainReform intends to … S. IPOs with IPO Edge research. Members of IPO Edge …

  • Pacira Pharmaceuticals Announces the Promotion of James S. Scibetta to President 20 Oct 2015 11:30 GMT

    … (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) … Company’s 2011 initial public offering and subsequent … Stack. About Pacira                                                                            Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX …

  • IPO Update: TELA Bio Files For $60 Million IPO 31 Oct 2019 19:24 GMT

    … Systems, Quaker Partners, OrbiMed, Pacira Pharmaceuticals, and Signet Healthcare Partners. … to prospective IPO investors. Assuming a successful IPO at … in the TELA IPO. Expected IPO Pricing Date: November … S. IPOs with IPO Edge research. Members of IPO Edge …

  • TELA Bio Starts $69 Million IPO Process 21 Oct 2019 21:05 GMT

    … Systems, Quaker Partners, OrbiMed, Pacira Pharmaceuticals, and Signet Healthcare Partners. … Listed underwriters of the IPO are Jefferies, Piper Jaffray … S. IPOs with IPO Edge research. Members of IPO Edge … get the latest IPO research, news …

  • The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs 22 Feb 2019 18:59 GMT

    … market close) Thursday, Feb. 28 Pacira Pharmaceuticals Inc (NASDAQ: PCRX) (before … ) (before the market open) IPO Kaleido Biosciences is planning to … 76 million shares in an IPO priced between $20 and … the ticker symbol KLDO. IPO Quiet Period Expiry INmune Bio …

  • Centrexion IPO: At Phase 3, But Don't Expect The Share Price To Go To The Moon 13 Nov 2018 18:45 GMT

    … in hand before the IPO seems sufficient to pay … these warrant liabilities after the IPO. The image below shows … million shares outstanding once the IPO goes live. At $15 … ; Co. (MRK) Novartis (NVS) Pacira Pharmaceuticals (PCRX) Pain Therapeutics (PTIE) Pfizer …

  • Liquidia IPO: Phase 3 Clinical Stage That Interested The Bill Gates Foundation 08 Aug 2018 16:04 GMT

    … shares outstanding after the IPO, the cash per share … good comparable peers of Liquidia. Pacira Pharmaceuticals, Inc. (PCRX) makes $ … investors prior to the IPO. The number of institutions … is somewhat usual in pharmaceutical IPOs, Liquidia’s partners are …

  • The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs 28 Jul 2018 18:18 GMT

    … See Also: Tricida Post-IPO Run-up Makes Goldman Wary … : RVNC) (after the close) Pacira Pharmaceuticals Inc (NASDAQ: PCRX) (before … Therapeutics Inc (NASDAQ: PETX) IPO Bionano Genomics, an instrumentation company … million shares in an IPO, with the price range …

Satisfied with the content?

Continue to create your account.